Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Avanir Pharma Nuedexta gets FDA approval
Avanir Pharma president and CEO Keith Katkin said that the FDA approval of Nuedexta marks an important milestone for people living with PBA. "The approval of Nuedexta also
Avanir Pharma president and CEO Keith Katkin said that the FDA approval of Nuedexta marks an important milestone for people living with PBA. "The approval of Nuedexta also
Idenix Pharma has posted a net loss of $12.93m for the third quarter 2010, or $0.18 per diluted share, compared to $11.67m, or $0.18 per diluted share, for
Major players profiled in the report titled ‘Specialty Enzymes: A Global Strategic Business Report’ include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Codexis, Danisco, Genencor International,
Revolade is an oral treatment that stimulates the production of blood platelets, which are essential to normal clotting. GSK claimed that the anti-allergic drug, Xyzal, has been approved
Metoprolol Tartrate injection, USP is the generic equivalent of Lopressor, which is marketed by Novartis International, and is used in the treatment of acute myocardial infarction (AMI). APP
Nexium is indicated for the treatment of gastroesophageal reflux disease. As per the terms of the agreement, AstraZeneca and Daiichi Sankyo will co-promote the product after it is
Taro Pharma has posted a net income of $18.86m for the third quarter 2010, or $0.46 per diluted share, compared to $9.73m, or $0.24 per diluted share, for
BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, and clinical supply chain design and
The cobas e 602 module, which uses Roche’s patented electrochemiluminescence (ECL) technology, includes more than 50 assays on its initial test menu and offers a throughput of up
Novartis said that the agreement is an extension to the existing relationship with Adesso Solutions and confirms they will continue to provide trade planning and execution, check request